Also trades as: SBFM (NASDAQ) · $vol 1M
SBFMW NASDAQ
Sunshine Biopharma, Inc.
1W: -19.0%
1M: -22.1%
3M: -70.5%
YTD: -85.5%
1Y: -88.6%
3Y: -94.7%
$0.03
-0.03 (-52.10%)
Weekly Expected Move ±71.6%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$35M
+44.7% ▲
5Y CAGR: +340.1%
Gross Profit
$11M
+28.0% ▲
5Y CAGR: +302.7%
Operating Income
-$6M
-21.5% ▼
Net Income
-$5M
-13.9% ▼
EPS (Diluted)
$-7.32
+97.9% ▲
EBITDA
-$5M
-34.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $71K | $228K | $4M | $24M | $35M |
| YoY Growth | +238.1% | +219.9% | +1802.6% | +454.4% | +44.7% |
| Cost of Revenue | $26K | $118K | $3M | $16M | $24M |
| Gross Profit | $46K | $111K | $2M | $8M | $11M |
| Gross Margin | 63.8% | 48.4% | 39.0% | 34.6% | 30.6% |
| R&D Expenses | $61K | $672K | $812K | $2M | $934K |
| SG&A Expenses | $547K | $2M | $9M | $11M | $15M |
| Operating Expenses | $622K | $3M | $10M | $13M | $16M |
| Operating Income | -$577K | -$2M | -$27M | -$5M | -$6M |
| Operating Margin | -807.8% | -1068.2% | -621.3% | -19.9% | -16.7% |
| Interest Expense | $168K | $329K | $39K | $137K | $9K |
| Income Before Tax | -$3M | -$12M | -$27M | -$4M | -$5M |
| Tax Expense | $0 | $0 | $233K | $395K | -$235K |
| Net Income | -$3M | -$12M | -$27M | -$5M | -$5M |
| Net Margin | -3898.7% | -5444.2% | -615.4% | -18.7% | -14.7% |
| EPS (Diluted) | $-3214.89 | $-9520.00 | $-3523.64 | $-351.36 | $-7.32 |
| EBITDA | -$3M | -$12M | -$26M | -$4M | -$5M |
| Shares Outstanding | 866 | 1306 | 7590 | 12165 | 701749 |